Pterisolic acid BCAS# 1401419-86-0 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1401419-86-0 | SDF | Download SDF |
PubChem ID | 53238558 | Appearance | Powder |
Formula | C20H26O4 | M.Wt | 330.4 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1S,3S,4S,5R,9R,13R)-3-hydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.01,10.04,9]hexadec-10-ene-5-carboxylic acid | ||
SMILES | CC12CCCC(C1C(CC34C2=CCC(C3)C(=C)C4=O)O)(C)C(=O)O | ||
Standard InChIKey | CSODFCSZYDJPLH-SEPLDZIRSA-N | ||
Standard InChI | InChI=1S/C20H26O4/c1-11-12-5-6-14-18(2)7-4-8-19(3,17(23)24)15(18)13(21)10-20(14,9-12)16(11)22/h6,12-13,15,21H,1,4-5,7-10H2,2-3H3,(H,23,24)/t12-,13+,15+,18+,19-,20+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Pterisolic acid B (J19) is an effective Nrf2 activator. we have also identified a more potent natural product analogue J19-1, J19-1 shows significant cytoprotective effect against cisplatin-induced cytotoxicity in HKC cells. |
Targets | Nrf2 |
Pterisolic acid B Dilution Calculator
Pterisolic acid B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.0266 mL | 15.1332 mL | 30.2663 mL | 60.5327 mL | 75.6659 mL |
5 mM | 0.6053 mL | 3.0266 mL | 6.0533 mL | 12.1065 mL | 15.1332 mL |
10 mM | 0.3027 mL | 1.5133 mL | 3.0266 mL | 6.0533 mL | 7.5666 mL |
50 mM | 0.0605 mL | 0.3027 mL | 0.6053 mL | 1.2107 mL | 1.5133 mL |
100 mM | 0.0303 mL | 0.1513 mL | 0.3027 mL | 0.6053 mL | 0.7567 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Pterisolic acid A
Catalog No.:BCN4842
CAS No.:1401419-85-9
- 15,16-Dihydroxyoctadeca-9Z,12Z-dienoic acid
Catalog No.:BCC8438
CAS No.:140129-22-2
- ML 277
Catalog No.:BCC7976
CAS No.:1401242-74-7
- PI-1840
Catalog No.:BCC5453
CAS No.:1401223-22-0
- 3'-Hydroxygynuramide II
Catalog No.:BCC8634
CAS No.:1401093-57-9
- AMG 925
Catalog No.:BCC5150
CAS No.:1401033-86-0
- Tannic acid
Catalog No.:BCN2643
CAS No.:1401-55-4
- 3-CPMT
Catalog No.:BCC6845
CAS No.:14008-79-8
- PB-22
Catalog No.:BCC1840
CAS No.:1400742-17-7
- Eucalyptin acetate
Catalog No.:BCN6216
CAS No.:14004-35-4
- 4μ8C
Catalog No.:BCC4754
CAS No.:14003-96-4
- Nystatin (Fungicidin)
Catalog No.:BCC4813
CAS No.:1400-61-9
- Pterisolic acid C
Catalog No.:BCN4838
CAS No.:1401419-87-1
- Pterisolic acid D
Catalog No.:BCN4839
CAS No.:1401419-88-2
- Pterisolic acid E
Catalog No.:BCN4841
CAS No.:1401419-89-3
- Pterisolic acid F
Catalog No.:BCN4840
CAS No.:1401419-90-6
- Epimedin A1
Catalog No.:BCN5935
CAS No.:140147-77-9
- ATPA
Catalog No.:BCC6940
CAS No.:140158-50-5
- Negundonorin A
Catalog No.:BCN7150
CAS No.:1401618-51-6
- (-)-Praeruptorin A
Catalog No.:BCN7664
CAS No.:14017-71-1
- Monnieriside G
Catalog No.:BCN7857
CAS No.:1401799-34-5
- Monnieriside A
Catalog No.:BCN7892
CAS No.:1401807-73-5
- (S)-(-)-5-Fluorowillardiine
Catalog No.:BCC6596
CAS No.:140187-23-1
- (S)-(-)-5-Iodowillardiine
Catalog No.:BCC6597
CAS No.:140187-25-3
Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain.[Pubmed:26757824]
Sci Rep. 2016 Jan 13;6:19231.
The use of chemoprotective agents to minimize the side effects of the chemotherapy, primarily via activation of the Nrf2 pathway, is an emerging research field, which has attracted broad attention from both academia and pharmaceutical industry. Through high-throughput chemical screens we have disclosed that Pterisolic acid B (J19), a naturally occuring diterpenoid, is an effective Nrf2 activator. We have also identified a more potent natural product analogue J19-1 by semisynthesis and the subsequent biochemical evaluations revealed that J19-1 activates the Nrf2 pathway by covalently modifying Cys171 of keap1, which inhibits Nrf2 degradation mediated by Keap1-Cul3 complexes. Ultimately, we have demonstrated that J19-1 shows significant cytoprotective effect against cisplatin-induced cytotoxicity in HKC cells.